NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
5.82
+0.08 (1.39%)
Oct 23, 2025, 1:35 PM EDT - Market open
NanoVibronix Market Cap
NanoVibronix has a market cap or net worth of $5.88 million as of October 23, 2025. Its market cap has increased by 281.22% in one year.
Market Cap
5.88M
Enterprise Value
4.14M
1-Year Change
281.22%
Ranking
Category
Stock Price
$5.82
Market Cap Chart
Since May 28, 2015, NanoVibronix's market cap has decreased from $6.43B to $5.88M, a decrease of -99.91%. That is a compound annual growth rate of -48.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 5.80M | 162.15% |
| Dec 31, 2024 | 2.21M | -5.92% |
| Dec 29, 2023 | 2.35M | -71.52% |
| Dec 30, 2022 | 8.26M | -97.82% |
| Dec 31, 2021 | 379.13M | -91.52% |
| Dec 31, 2020 | 4.47B | -76.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.04B |
| Johnson & Johnson | 465.22B |
| AbbVie | 405.94B |
| UnitedHealth Group | 326.23B |
| AstraZeneca | 259.95B |
| Novartis AG | 254.71B |
| Novo Nordisk | 245.28B |
| Abbott Laboratories | 224.00B |